Akt1 Antibodies

Santa Cruz Biotechnology provides a broad selection of Akt1 monoclonal antibodies for research focused on understanding Akt1 protein's role in cellular processes. Akt1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Akt1, also known as Protein Kinase B alpha, is a key regulator of cell survival, growth, and metabolism. It plays a vital role in the phosphoinositide 3-kinase (PI3K) signaling pathway, which is crucial for mediating cellular responses to growth factors and insulin. Dysregulation of Akt1 has been implicated in various diseases, including cancer, making it an important target for therapeutic intervention. Akt1 monoclonal antibodies enable detailed investigation of signaling pathways and molecular mechanisms in both normal and pathological conditions. Researchers can utilize Akt1 monoclonal antibodies to examine protein expression patterns across different tissue types and cellular compartments. Advanced detection methods incorporating horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates provide versatile visualization options. Santa Cruz Biotechnology monoclonal antibodies for Akt1 support researchers worldwide in advancing our understanding of cellular signaling and disease mechanisms.